Eli Lilly's Zepbound Approval Shakes Up Healthcare Stocks
FDA approval of Eli Lilly's Zepbound impacts healthcare stocks, notably affecting ResMed and Inspire Medical Systems. Stay updated on market changes.
Topic
FDA decision
A collection of 1 issue